• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The case for reassessment of health care technology. Once is not enough.

作者信息

Banta H D, Thacker S B

机构信息

The Netherlands Organization for Applied Scientific Research, The Hague.

出版信息

JAMA. 1990 Jul 11;264(2):235-40.

PMID:2355445
Abstract

Assessment of health care technologies should be an iterative process, not a single event. In the United States there are an increasing number of organized attempts at reassessment of technologies by the health industry, professional societies, and national government agencies, such as the Medical Necessity Project of Blue Cross/Blue Shield, the Clinical Efficacy Assessment Project of the American College of Physicians, and the work of the US Preventive Services Task Force. We examine four clinical practices--electronic fetal monitoring, episiotomy, electroencephalography, and hysterectomy--to illustrate the need to continuously reassess existing technologies and to challenge our current inertia in this critical arena of health practice.

摘要

相似文献

1
The case for reassessment of health care technology. Once is not enough.
JAMA. 1990 Jul 11;264(2):235-40.
2
Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.将低价值医疗清单付诸行动:利用行政数据对候选健康技术进行重新评估的优先级排序。
BMC Health Serv Res. 2018 Aug 15;18(1):640. doi: 10.1186/s12913-018-3459-1.
3
Technology assessment in medicine: methods, status and trends.医学技术评估:方法、现状与趋势
Med Prog Technol. 1991;17(2):69-75.
4
Health technology reassessment of non-drug technologies: current practices.非药物技术的卫生技术重新评估:当前实践。
Int J Technol Assess Health Care. 2012 Jul;28(3):220-7. doi: 10.1017/S0266462312000438.
5
ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.美国心脏病学会基金会/美国心脏协会心血管技术质量指标制定方法学:美国心脏病学会基金会/美国心脏协会绩效指标工作组的报告。
J Am Coll Cardiol. 2011 Sep 27;58(14):1517-38. doi: 10.1016/j.jacc.2011.07.007. Epub 2011 Aug 29.
6
The Blue Cross Blue Shield Association Technology Evaluation Center: how we evaluate radiology technologies.蓝十字蓝盾协会技术评估中心:我们如何评估放射技术。
J Am Coll Radiol. 2005 Jan;2(1):33-8. doi: 10.1016/j.jacr.2004.07.002.
7
[Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].克罗地亚的医疗保健质量、认证与卫生技术评估:卫生质量与认证机构的作用
Acta Med Croatica. 2010 Dec;64(5):425-34.
8
The assessment process: a microscopic view.
Med Prog Technol. 1991;17(2):77-83.
9
Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.面向医疗保险人群的远程医疗:儿科、产科及临床医生间接居家干预措施
Evid Rep Technol Assess (Summ). 2001 Aug(24 Suppl):1-32.
10
The medical technologist and evaluation of health technologies.医学技术专家与卫生技术评估
Am J Med Technol. 1980 Jan;46(1):30-2.

引用本文的文献

1
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework.健康与医学中基于模型的决策的迭代方法指南:迭代决策框架。
Pharmacoeconomics. 2024 Apr;42(4):363-371. doi: 10.1007/s40273-023-01341-z. Epub 2023 Dec 29.
2
Conceptualising characteristics of resources withdrawal from medical services: a systematic qualitative synthesis.医疗服务资源撤离的特征概念化:一项系统性定性综合研究。
Health Res Policy Syst. 2020 Oct 28;18(1):123. doi: 10.1186/s12961-020-00630-9.
3
Addressing overuse of health services in health systems: a critical interpretive synthesis.
解决卫生系统中卫生服务利用过度问题:批判性综合分析。
Health Res Policy Syst. 2018 Jun 15;16(1):48. doi: 10.1186/s12961-018-0325-x.
4
Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.英国糖尿病预防研究(ADDITION-UK)试验中通过筛查发现的2型糖尿病患者强化治疗的增量成本与成本效益:基于实证试验成本数据的更新
Value Health. 2017 Dec;20(10):1288-1298. doi: 10.1016/j.jval.2017.05.018. Epub 2017 Jul 4.
5
Identifying low-value clinical practices in critical care medicine: protocol for a scoping review.识别重症医学中的低价值临床实践:一项范围综述的方案
BMJ Open. 2015 Oct 28;5(10):e008244. doi: 10.1136/bmjopen-2015-008244.
6
Towards understanding the de-adoption of low-value clinical practices: a scoping review.关于理解低价值临床实践的弃用:一项范围综述
BMC Med. 2015 Oct 6;13:255. doi: 10.1186/s12916-015-0488-z.
7
A practical guide to value of information analysis.信息价值分析实用指南。
Pharmacoeconomics. 2015 Feb;33(2):105-21. doi: 10.1007/s40273-014-0219-x.
8
Delayed assessment and eager adoption of laparoscopic cholecystectomy: implications for developing surgical technologies.延迟评估和急切采用腹腔镜胆囊切除术:对开发外科技术的影响。
World J Gastroenterol. 2010 Sep 7;16(33):4115-22. doi: 10.3748/wjg.v16.i33.4115.
9
Midline versus mediolateral episiotomy.会阴正中切开术与会阴侧切术
BMJ. 2000 Jun 17;320(7250):1615-6. doi: 10.1136/bmj.320.7250.1615.
10
Basic concepts and fundamental issues in technology assessment.技术评估中的基本概念与根本问题。
Intensive Care Med. 1993;19(2):117-21. doi: 10.1007/BF01708374.